Sage Journals: Discover world-class research

Retricted access

Research article

First published 2012-1

Latanoprost 0.005% Test Formulation is as Effective as Xalatan® in Patients with Ocular Hypertension and Primary Open-Angle Glaucoma

Catherine Allaire, Alice Dietrich, Helmut Allmeier [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2012-10

Intraocular Pressure–Lowering Effect of 0.005% Latanoprost with Two Different Dosing Regimens

Naveed Nilforushan, Ali Naghibi, Siamak Shokrollahi [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Research article

First published 2000-12

Therapeutic Success of Latanoprost 0.005% Compared to Brimonidine 0.2% in Patients with Open-Angle Glaucoma or Ocular Hypertension

WILLIAM C. STEWART, DOUGLAS G. DAY, JEANETTE A. STEWART [...]

Journal of Ocular Pharmacology and Therapeutics

Open access

Review article

First published 2021-01

Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

Javier F. Casiraghi, Daniel Grigera, J. Alejo Peyret [...]

DNA and Cell Biology Reports

Retricted access

Research article

First published 2011-12

Ocular Hypotensive Effects and Safety over 3 Months of Switching from an Unfixed Combination to Latanoprost 0.005%/Timolol Maleate 0.5% Fixed Combination

Kenji Inoue, Ryoko Okayama, Risako Higa [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Research article

First published 2024-9

The long-term effects of topical latanoprost 0.005% treatment on pupillary functions: A 2-year longitudinal study

Serdar Bayraktar, Gözde Hondur, Mehmet Ali Şekeroğlu [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2023-11

Pharmacokinetic and Ocular Toxicity Evaluation of Latanoprost Ophthalmic Solution,0.005%,with Preservative Level Reduced to Below the Limit of Quantitation

Srini Venkatesh, Mary Richardson

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Research article

First published 2000-06

Comparison of the Efficacy and Safety of Latanoprost 0.005% Compared to Brimonidine 0.2% or Dorzolamide 2% When Added to a Topical β-Adrenergic Blocker in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

WILLIAM C. STEWART, ELIZABETH D. SHARPE, DOUGLAS G. DAY [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Research article

First published 1999-02

The Use of Latanoprost 0.005% Once Daily and its Effect on Intraocular Pressure as Primary or Adjunctive Therapy

SHANNON L. SMITH, CHERYL S. SINE, CAROLINE A. PRUITT [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Research article

First published 2007-3

A 1-Year Study to Compare the Efficacy and Safety of Once-Daily Travoprost 0.004%/Timolol 0.5% to Once-Daily Latanoprost 0.005%/Timolol 0.5% in Patients with Open-Angle Glaucoma or Ocular Hypertension

F. Topouzis, S. Melamed, H. Danesh-meyer [...]

European Journal of Ophthalmology

Search results